1110. In Vivo Pharmacodynamics of Vancomycin Against Staphylococci in Young Infants

BACKGROUND: Coagulase-negative staphylococci are the predominant pathogen causing late onset sepsis in young infants, however, the pharmacodynamic target for vancomycin therapy is unknown. This study aimed to determine the pharmacodynamic target of vancomycin in young infants with staphylococcal inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Gwee, Amanda, Duffull, Stephen, Zhu, Derek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644379/
http://dx.doi.org/10.1093/ofid/ofab466.1304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644379/
http://dx.doi.org/10.1093/ofid/ofab466.1304

Ejemplares similares